CNBC Television published this video item, entitled “Evidence to approve of Biogen’s Alzheimer’s drug was not ‘sufficient,’ says Penn’s Dr. Jason Karlawi” – below is their description.
Dr. Jason Karlawish, co-director of the University of Pennsylvania Medical Center, joins ‘The News with Shepard Smith’ to discuss the new Alzheimer’s drug, saying that the evidence to approve the drug “was not sufficient.”CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.